Scleroderma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 7: Line 7:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence of scleroderma is approximately 0.23 to 2.28 cases per 100,000 individuals worldwide.<ref name="pmid17692364">{{cite journal |vauthors=Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J |title=Incidence and prevalence of systemic sclerosis: a systematic literature review |journal=Semin. Arthritis Rheum. |volume=37 |issue=4 |pages=223–35 |date=February 2008 |pmid=17692364 |doi=10.1016/j.semarthrit.2007.05.003 |url=}}</ref>
*The incidence of scleroderma is approximately 2 per 100,000 individuals in the United States.<ref name="pmid12841293">{{cite journal |vauthors=Mayes MD |title=Scleroderma epidemiology |journal=Rheum. Dis. Clin. North Am. |volume=29 |issue=2 |pages=239–54 |date=May 2003 |pmid=12841293 |doi= |url=}}</ref>
*The incidence of scleroderma is approximately 2 per 100,000 individuals in the United States.<ref name="pmid12841293">{{cite journal |vauthors=Mayes MD |title=Scleroderma epidemiology |journal=Rheum. Dis. Clin. North Am. |volume=29 |issue=2 |pages=239–54 |date=May 2003 |pmid=12841293 |doi= |url=}}</ref>


===Prevalence===
===Prevalence===
*The prevalence of scleroderma is approximately 5 to 30 cases per 100,000 individuals worldwide.<ref name="pmid17692364">{{cite journal |vauthors=Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J |title=Incidence and prevalence of systemic sclerosis: a systematic literature review |journal=Semin. Arthritis Rheum. |volume=37 |issue=4 |pages=223–35 |date=February 2008 |pmid=17692364 |doi=10.1016/j.semarthrit.2007.05.003 |url=}}</ref>
*In 1990, the prevalence of scleroderma was estimated to be 27.6 cases per 100,000 individuals in the united states.<ref name="pmid17692364">{{cite journal |vauthors=Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J |title=Incidence and prevalence of systemic sclerosis: a systematic literature review |journal=Semin. Arthritis Rheum. |volume=37 |issue=4 |pages=223–35 |date=February 2008 |pmid=17692364 |doi=10.1016/j.semarthrit.2007.05.003 |url=}}</ref>
*In 1990, the prevalence of scleroderma was estimated to be 27.6 cases per 100,000 individuals in the united states.<ref name="pmid17692364">{{cite journal |vauthors=Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J |title=Incidence and prevalence of systemic sclerosis: a systematic literature review |journal=Semin. Arthritis Rheum. |volume=37 |issue=4 |pages=223–35 |date=February 2008 |pmid=17692364 |doi=10.1016/j.semarthrit.2007.05.003 |url=}}</ref>
*The prevalence of scleroderma is approximately 24 cases per 100,000 individuals in the United States.<ref name="pmid12841293">{{cite journal |vauthors=Mayes MD |title=Scleroderma epidemiology |journal=Rheum. Dis. Clin. North Am. |volume=29 |issue=2 |pages=239–54 |date=May 2003 |pmid=12841293 |doi= |url=}}</ref>
*The prevalence of scleroderma is approximately 24 cases per 100,000 individuals in the United States.<ref name="pmid12841293">{{cite journal |vauthors=Mayes MD |title=Scleroderma epidemiology |journal=Rheum. Dis. Clin. North Am. |volume=29 |issue=2 |pages=239–54 |date=May 2003 |pmid=12841293 |doi= |url=}}</ref>

Revision as of 15:58, 29 March 2018

Scleroderma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Scleroderma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Scleroderma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Scleroderma epidemiology and demographics

CDC on Scleroderma epidemiology and demographics

Scleroderma epidemiology and demographics in the news

Blogs on Scleroderma epidemiology and demographics

Directions to Hospitals Treating Scleroderma

Risk calculators and risk factors for Scleroderma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence of scleroderma is approximately 0.23 to 2.28 cases per 100,000 individuals worldwide.[1]
  • The incidence of scleroderma is approximately 2 per 100,000 individuals in the United States.[2]

Prevalence

  • The prevalence of scleroderma is approximately 5 to 30 cases per 100,000 individuals worldwide.[1]
  • In 1990, the prevalence of scleroderma was estimated to be 27.6 cases per 100,000 individuals in the united states.[1]
  • The prevalence of scleroderma is approximately 24 cases per 100,000 individuals in the United States.[2]

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • Choctaw native americans from southeastern Oklahoma were reported to have much higher prevalence of scleroderma than the general population.[3]
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • Females are more commonly affected by scleroderma than males. The female to male ratio is approximately 4 to 1.[4]

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. ↑ 1.0 1.1 1.2 Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (February 2008). "Incidence and prevalence of systemic sclerosis: a systematic literature review". Semin. Arthritis Rheum. 37 (4): 223–35. doi:10.1016/j.semarthrit.2007.05.003. PMID 17692364.
  2. ↑ 2.0 2.1 Mayes MD (May 2003). "Scleroderma epidemiology". Rheum. Dis. Clin. North Am. 29 (2): 239–54. PMID 12841293.
  3. ↑ Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD (August 1996). "Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype". Arthritis Rheum. 39 (8): 1362–70. PMID 8702445.
  4. ↑ "Systemic scleroderma - Genetics Home Reference".

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Scleroderma_epidemiology_and_demographics&oldid=1457633"